Turn Therapeutics (TTRX) Assets (2024 - 2026)

Turn Therapeutics' Assets history runs 3 years deep, the most recent figure standing at $18.6 million for Q1 2026.

• In Q1 2026, Assets changed N/A year-over-year to $18.6 million; the TTM figure through Mar 2026 stood at $18.6 million (changed N/A YoY), while the FY2025 annual figure was $12.2 million, up 493.6% from the prior year.
• Assets was $18.6 million for Q1 2026 at Turn Therapeutics, up from $12.2 million in the prior quarter.
• In the past five years, Assets ranged from a high of $18.6 million in Q1 2026 to a low of $2.0 million in Q4 2024.
• Historically, Assets has averaged $9.3 million across 3 years, with a median of $8.2 million in 2025.
• Biggest YoY gain for Assets was 493.6% in 2025; the steepest drop was 493.6% in 2025.
• A 3-year view of Assets shows it stood at $2.0 million in 2024, then jumped by 493.6% to $12.2 million in 2025, then jumped by 53.3% to $18.6 million in 2026.
• The last three Assets figures came in at $18.6 million (Q1 2026), $12.2 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.